Trial Profile
Using Latent Variables and Directly Observed Treatment to Improve the Diagnosis and Management of Depression Among Hemodialysis Patients
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 17 Mar 2023
Price :
$35
*
At a glance
- Drugs Fluoxetine (Primary)
- Indications Depression
- Focus Therapeutic Use
- 15 Mar 2023 Status changed from recruiting to completed.
- 27 Sep 2022 Planned End Date changed from 30 Nov 2023 to 30 Mar 2023.
- 27 Sep 2022 Planned primary completion date changed from 30 Nov 2023 to 30 Jan 2023.